FibroGENE: A gene-based model for staging liver fibrosis

Journal of Hepatology

Volumn 64, Issue 2, 2016, Pages 390-398

  Eslam, Mohammed ^a   Hashem, Ahmed M ^b   Romero Gomez, Manuel ^c   Berg, Thomas ^d,e   Dore, Gregory J ^f,g   Mangia, Alessandra ^h   Chan, Henry Lik Yuen ⁱ   Irving, William L ^j   Sheridan, David ^k,l   Abate, Maria Lorena ^m   Adams, Leon A ⁿ   Weltman, Martin ^o   Bugianesi, Elisabetta ^m   Spengler, Ulrich ^p   Shaker, Olfat ^q   Fischer, Janett ^d   Mollison, Lindsay ^r   Cheng, Wendy ^s   Nattermann, Jacob ^p   Riordan, Stephen ^t   Miele, Luca ^u   Kelaeng, Kebitsaone Simon ^a   Ampuero, Javier ^c   Ahlenstiel, Golo ^a   McLeod, Duncan ^v   Powell, Elizabeth ^w,x   Liddle, Christopher ^a   Douglas, Mark W ^a   Booth, David R ^a   George, Jacob ^a   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b Minia University   (Egypt)

^c HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁱ CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^j UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

^l UNIVERSITY OF PLYMOUTH   (United Kingdom)

^m UNIVERSITY OF TURIN   (Italy)

ⁿ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^o NEPEAN HOSPITAL   (Australia)

^p UNIVERSITY OF BONN   (Germany)

^q CAIRO UNIVERSITY   (Egypt)

^r FREMANTLE HOSPITAL   (Australia)

^s ROYAL PERTH HOSPITAL   (Australia)

^t UNIVERSITY OF NEW SOUTH WALES   (Australia)

^u CATHOLIC UNIVERSITY   (Italy)

^v WESTMEAD HOSPITAL   (Australia)

^w PRINCESS ALEXANDRA HOSPITAL   (Australia)

^x UNIVERSITY OF QUEENSLAND   (Australia)

more..

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Data mining analysis; Fibrosis; IFNL; NASH; Non alcoholic steatohepatitis

Indexed keywords

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; DECISION TREE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FEMALE; FIB 4 INDEX; FIBROGENE DT MODEL; FORNS INDEX; GENETIC MARKER; HUMAN; INTERMETHOD COMPARISON; LIVER FIBROSIS; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NONALCOHOLIC FATTY LIVER FIBROSIS SCORE; PREDICTIVE VALUE; PRIORITY JOURNAL; STAGING; ALGORITHM; BIOPSY; DISEASE COURSE; GENETICS; HEPATITIS, CHRONIC; LIVER; LIVER CIRRHOSIS; METHODOLOGY; MIDDLE AGED; MUTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT ACUITY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

GENETIC MARKER; IFNL4 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; ALGORITHMS; BIOPSY; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HEPATITIS, CHRONIC; HUMANS; INTERLEUKINS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUTATION; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT ACUITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 84954366506     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.11.008     Document Type: Article

References (53)

1. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 2007 539 548
2. WHO. Viral hepatitis: report by the Secretariat, March 2010.
3. O. Cheung, and A.J. Sanyal Recent advances in NAFLD Curr Opin Gastroenterol 26 2010 202 208
4. D.S. Manning, and N.H. Afdhal Diagnosis and quantitation of fibrosis Gastroenterology 134 2008 1670 1681
5. A. Regev, M. Berho, L.J. Jeffers, C. Milikowski, E.G. Molina, N.T. Pyrsopoulos, and et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
6. V. Ratziu, F. Charlotte, A. Heurtier, S. Gombert, P. Giral, E. Bruckert, and et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 2005 1898 1906
7. L.A. Adams, and A.E. Feldstein Nonalcoholic steatohepatitis: risk factors and diagnosis Expert Rev Gastroenterol Hepatol 4 2010 623 635
8. T. Poynard, M. Munteanu, F. Imbert-Bismut, F. Charlotte, D. Thabut, S. Le Calvez, and et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 2004 1344 1355
9. L. Castéra, P.H. Bernard, B. Le Bail, J. Foucher, P. Trimoulet, W. Merrouche, and et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers Aliment Pharmacol Ther 33 2011 455 465
10. B. Coco, F. Oliveri, A.M. Maina, P. Ciccorossi, R. Sacco, P. Colombatto, and et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepatol 14 2007 360 369
11. M. Fraquelli, C. Rigamonti, G. Casazza, D. Conte, M.F. Donato, G. Ronchi, and et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 2007 968 973
12. P. Marcellin, M. Ziol, P. Bedossa, C. Douvin, R. Poupon, V. de Lédinghen, and et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B Liver Int 29 2009 242 247
13. F. Oliveri, B. Coco, P. Ciccorossi, and et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases World J Gastroenterol 14 2008 6154 6162
14. D. Festi, R. Schiumerini, L. Marzi, A.R. Di Biase, D. Mandolesi, L. Montrone, and et al. The diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods Aliment Pharmacol Ther 37 2013 392 400
15. M. Yoneda, M. Yoneda, H. Mawatari, K. Fujita, H. Endo, H. Iida, and et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) Dig Liver Dis 40 2008 371 378
16. M. Eslam, A.M. Hashem, R. Leung, M. Romero-Gomez, T. Berg, G.J. Dore, and et al. Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease Nat Commun 6 2015 6422
17. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289
18. J.R. Dixon Jr. The international conference on harmonization good clinical practice guideline Qual Assur 6 2 1998 65 74
19. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 27 2004 s5 s10
20. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram, and et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
21. R.K. Sterling, E. Lissen, N. Clumeck, R. Sola, M.C. Correa, J. Montaner, and et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 2006 1317 1325
22. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, G.C. Farrell, and et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854
23. X. Forns, S. Ampurdanès, J.M. Llovet, J. Aponte, L. Quintó, E. Martínez-Bauer, and et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
24. D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, E. Del Vecchio, and et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 2002 1 10
25. M. Eslam, R. Leung, M. Romero-Gomez, A. Mangia, W.L. Irving, D. Sheridan, and et al. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection J Hepatol 61 2014 235 241
26. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, O.W. Cummings, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
27. T.M. Cover, and P.E. Hart Nearest neighbor pattern classification IEEE Trans Info Theory IT-13 1967 21 27
28. Lewis RJ. An introduction to classification and regression tree (CART) analysis. Available at: < http://www.saem.org/download/lewis1.pdf >. Accessed July 8, 2013.
29. W.G. Baxt Application of artificial neural networks to clinical medicine Lancet 346 1995 1135 1138
30. A. Das, T. Ben-Menachem, G.S. Cooper, A. Chak, M.V. Sivak Jr., J.A. Gonet, and et al. Prediction of outcome in acute lower-gastrointestinal haemorrhage based on an artificial neural network: internal and external validation of a predictive model Lancet 362 2003 1261 1266
31. M. Kurosaki, Y. Tanaka, N. Nishida, N. Sakamoto, N. Enomoto, M. Honda, and et al. Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors J Hepatol 54 2011 439 448
32. A.M. Hashem, M.E. Rasmy, K.M. Wahba, and O.G. Shaker Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis C infection Comput Methods Programs Biomed 105 2012 194 209
33. G. Shafer A mathematical theory of evidence 1976 Princeton University Press New York
34. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
35. B. Sahiner, H.P. Chan, and L. Hadjiiski Classifier performance estimation under the constraint of a finite sample size: resampling schemes applied to neural network classifiers Neural Netw 21 2008 476 483
36. Y. Vergouwe, E.W. Steyerberg, M.J. Eijkemans, and J.D. Habbema Substantial effective sample sizes were required for external validation studies of predictive logistic regression models J Clin Epidemiol 58 2005 475 483
37. N.A. Obuchowski Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary Acad Radiol 12 2005 1198 1204
38. J. Lambert, P. Halfon, G. Penaranda, and et al. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited Clin Chem 54 2008 1372 1378
39. T. Poynard, P. Halfon, L. Castera, M. Munteanu, F. Imbert-Bismut, V. Ratziu, and et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages Clin Chem 53 2007 1615 1622
40. A.R. Donders, G.J. van der Heijden, T. Stijnen, and K.G. Moons Review: a gentle introduction to imputation of missing values J Clin Epidemiol 59 2006 1087 1091
41. O. Harel, and X.H. Zhou Multiple imputation: review of theory, implementation and software Stat Med 26 2007 3057 3077
42. M. Ekstedt, H. Hagström, P. Nasr, M. Fredrikson, P. Stål, S. Kechagias, and et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 2015 1547 1554
43. G. D'Amico, G. Garcia-Tsao, and L. Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Hepatol 44 2006 217 231
44. N. Graudal, P. Leth, L. Mårbjerg, and A.M. Galløe Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies J Intern Med 230 1991 165 171
45. K. Fujimoto, M. Sawabe, M. Sasaki, K. Kino, and T. Arai Undiagnosed cirrhosis occurs frequently in the elderly and requires periodic follow ups and medical treatments Geriatr Gerontol Int 8 2008 198 203
46. E.B. Tapper, L. Castera, and N.H. Afdhal FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice Clin Gastroenterol Hepatol 13 2015 27 36
47. C. Koh, X. Zhao, N. Samala, S. Sakiani, T.J. Liang, and J.A. Talwalkar AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations Hepatology 58 2013 2142 2152
48. EASL Clinical Practice Guidelines Management of hepatitis C virus infection J Hepatol 60 2014 392 420
49. H. Huang, C. Benner, N. Spann, R. Venkatesh, N. Bzowej, O.T. Abar, and et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C Hepatology 46 2007 297 306
50. E. Trepo, A. Potthoff, P. Pradat, R. Bakshi, B. Young, R. Lagier, and et al. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease J Hepatol 55 2011 38 44
51. M. Marcolongo, B. Young, F. Dal Pero, G. Fattovich, L. Peraro, M. Guido, and et al. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C Hepatology 50 2009 1038 1044
52. J. Shen, H.L. Chan, G. Wong, W.H. Chan A, H.Y. Chan, and V.W. Wong The cirrhosis risk score is not associated with liver fibrosis/cirrhosis and fibrosis progression in Chinese non-alcoholic fatty liver disease patients Gastroenterology 142 2012 S1017
53. A. Fernández-Rodríguez, J. Berenguer, M.A. Jiménez-Sousa, M. Guzmán-Fulgencio, D. Micheloud, P. Miralles, and et al. Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers J Acquir Immune Defic Syndr 64 2013 434 442